Skip to main content
. 2020 Oct 26;5:17. doi: 10.1038/s41536-020-00105-z

Table 2.

Delivery method and number of cell doses for MSC therapy for COVID-19 related conditions (Clinicaltrials.gov).

Delivery method Total number (%) Number of doses to be administered
1 2 3 4 5 Unknown
Intramuscular injection 1 (2.6) 1* 0 0 0 0 0
Intravenous 36 (92.3) 5 6 10 5 2 8
Unknown 2 (5.1) 1 1 0 0 0 0
Total # of doses (%) 7 (17.9) 7 (17.9) 10 (25.6) 5 (12.8) 2 (5.1) 8 (20.5)

1*—Subjects randomized to high dose cohort may receive an additional dose.